|Articles|April 1, 2016

Redefining Easy

The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the United States and Canada, offers a broad range of products that span from research and development to production. Visit booth #2841 to learn how our new product innovations will help you simplify your manufacturing processes, allowing you to advance your molecules to market faster and more cost effectively.

MilliporeSigma
INTERPHEX Booth #2841

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Redefining Easy

Newsletter

Trending on BioPharm International

VectorY Doses First Patient in TDP-43–Targeting ALS Trial

FDA Clears In-Vivo Gene Editing Therapy PBGENE-DMD for Duchenne Trial

Women in STEM: Building Sustainable Cost and Access Models for Advanced Therapies (Part 1)

Speed-to-IND Starts with Toxicology: A Rapid-Fire Q&A with Lonza

Ivonescimab Breakthrough Designation Highlights Progress in BTC Treatment